Episurf Medical (NASDAQ: EPIS B) will exhibit at the 35th AGA Congress (one of the major orthopaedic congresses in the DACH region), held in Linz, Austria (Design Center Linz), on September 13-15. At the congress, Priv.-Doz. Dr. med. Clemens Kösters (Maria-Josef-Hospital, Greven, Germany) will present the 2-year follow-up of his patients treated with Episealer®.
For full program, see http://aga-kongress.info/. For an overview of the industry conferences attended by Episurf Medical, see link. (www.episurf.com/healthcare-professionals/conferences).
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalised treatment alternatives. Episurf Medical’s Episealer® personalised implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.